Note: Ingredients listed on restricted chemical lists
EC/CAS
247-852-1/26628-22-8
Name of the chemical
Sodium Azide
Concentration
0.79%
EC/CAS
250-001-7/30007-47-7
Name of the chemical
5-Bromo-5-nitro-1,3-dioxane
Concentration
0.19%
General Information
Revision date
2018-10-07
Product name
ARCHITECT Concentrated Wash Buffer
1.2.1 Relevant identified uses
For In Vitro Diagnostic Use
1.2.2. Uses advised against
No further relevant information available
supplier name
Abbott GmbH & Co. KG
Emergency telephone
(+49)-6122-58-0 (English only
Icons in SDS
Company Information
company name
Abbott GmbH & Co. KG
e-mail address of the competent person responsible for the Safety Data Sheet
MSDS-Support@Abbott.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H412
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
CLP CLASSIFICATION
Acute Tox. 4 H302 Harmful if swallowed. Aquatic Chronic 3 H412 Harmful to aquatic life with long lasting effects.
Additional information
Testing has been done on a similar material to determine the hazards EUH032 Contact with acids liberates very toxic gas.
2.2 Label elements
Labelling according to Regulation (EC) No 1272/2008: The product is classified and labelled according to the CLP regulation.
Hazardous Ingredients
Sodium azide Trade name: ARCHITECT Concentrated Wash Buffer (Continued from page 1)
Hazard statements
H302 Harmful if swallowed. H412 Harmful to aquatic life with long lasting effects.
Precautionary statements
P220 Keep away from acids. P260 Do not breathe mist / vapours / spray. P273 Avoid release to the environment. P280 Wear protective gloves/protective clothing/eye protection. P301+P330+P312 IF SWALLOWED: Rinse mouth. Call a POISON CENTER or doctor / physician if you feel unwell. P304+P312 IF INHALED: Call a POISON CENTER/doctor if you feel unwell. P501 Dispose of contents / container in accordance with local regulations.
Contains
5-Bromo-5-nitro-1,3-dioxane. May produce an allergic reaction
Principle Routes of Exposure
Skin: No adverse effects expected when used as directed. - Eye: No adverse effects expected when used as directed. - Inhalation: No adverse effects expected when used as directed. - Ingestion: No adverse effects expected when used as directed.
PBT Substances
Not applicable
vPvB Substances
Not applicable *
